Literature DB >> 11809008

The medicalization of menopause: critique and consequences.

V F Meyer1.   

Abstract

Menopause is in the process of becoming medicalized. Midlife and older women are being told that natural menopause is actually a deficiency condition requiring replacement hormones to maintain health and increase longevity. The three major diseases that are being linked with the lower estrogen levels of midlife and older women are heart disease, osteoporosis and, most recently, Alzheimer's disease. Primary prevention of these diseases is the rationale used for urging healthy women to take long-term hormones. Although there have been many challenges to these links and warnings against the widespread use of hormones, they have been either ignored or trivialized. In this article, the author examines mortality and morbidity statistics across and within nations and over time, critiques the major arguments used to support the notion that menopause places women at an increased risk of disease and that exogenous hormones reduce this risk, and discusses the adverse consequences of defining all midlife and older women as hormonally deficient and in need of medical intervention.

Entities:  

Mesh:

Year:  2001        PMID: 11809008     DOI: 10.2190/M77D-YV2Y-D5NU-FXNW

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  2 in total

1.  Marketing Experimental Stem Cell Therapies in the UK: Biomedical Lifestyle Products and the Promise of Regenerative Medicine in the Digital Era.

Authors:  Sonja Erikainen; Anna Couturier; Sarah Chan
Journal:  Sci Cult (Lond)       Date:  2019-09-24

2.  Quaternary prevention and menopause.

Authors:  Bharti Kalra; Sonia Malik
Journal:  J Midlife Health       Date:  2014-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.